scholarly journals Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial

Epilepsia ◽  
2021 ◽  
Author(s):  
Anup D. Patel ◽  
Maria Mazurkiewicz‐Bełdzińska ◽  
Richard F. Chin ◽  
Antonio Gil‐Nagel ◽  
Boudewijn Gunning ◽  
...  
Keyword(s):  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Extension Trial

scholarly journals Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial

Epilepsia ◽  
2012 ◽  
Vol 53 (3) ◽  
pp. 521-528 ◽  
Author(s):  
Aatif Husain ◽  
Steve Chung ◽  
Edward Faught ◽  
Jouko Isojarvi ◽  
Cindy McShea ◽  
...  
Keyword(s):  
Phase Iii ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Extension Trial

Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8years

2014 ◽  
Vol 41 ◽  
pp. 164-170 ◽  
Author(s):  
William Rosenfeld ◽  
Nathan B. Fountain ◽  
Gintaras Kaubrys ◽  
Elinor Ben-Menachem ◽  
Cindy McShea ◽  
...  
Keyword(s):  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Extension Trial

Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome in an Open-label Extension Trial (GWPCARE5)

2019 ◽  
Vol 101 ◽  
pp. 106729
Author(s):  
Richard Chin ◽  
Anup Patel ◽  
Antonio Gil-Nagel ◽  
Wendy Mitchell ◽  
M. Scott Perry ◽  
...  
Keyword(s):  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Extension Trial
Sign in / Sign up

Export Citation Format

Share Document